Company / Cost of Revenue
Jaguar Health, Inc. Cost of Revenue History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$97.0K
FY2025
5-year range
$97.0K / $3.8M
FY2021-FY2025
Trend
-95.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cost of Revenue has declined for 3 consecutive years, from $4M in FY2020 to $97,000 in FY2025.
Based on SEC 10-K filings.
$97,000 in FY2025 with a 10-year CAGR of -2.4%.
Improved from $2M to $97,000 over the past 3 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -65.4%
- 5-Year CAGR
- -52.0%
- 10-Year CAGR
- -2.4%
Key checks
Key Insights
- Jaguar Health, Inc.'s cost of revenue has declined for 3 consecutive years.
- 5-year CAGR of -52.0%, indicating a declining trend.
- In FY2025, cost of revenue decreased 95.2% year-over-year.
- Peak cost of revenue was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.49 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $97.0K | -95.2% |
| FY2024 | $2.0M | -12.7% |
| FY2022 | $2.3M | -38.9% |
| FY2020 | $3.8M | +38.0% |
| FY2019 | $2.8M | +214.1% |
| FY2018 | $880.4K | +1594.2% |
| FY2017 | $52.0K | -57.9% |
| FY2016 | $123.5K | +0.0% |
| FY2015 | $123.5K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026